CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A /

CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing.Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution.

Bibliographic Details
Main Author: Singh, Vijay, 1950- (Author)
Corporate Author: ScienceDirect (Online service)
Format: eBook
Language:English
Published: London, England : Academic Press, [2024]
Edition:First edition.
Series:Progress in Molecular Biology and Translational Science Series.
Subjects:
Online Access:Connect to the full text of this electronic book
Description
Summary:CRISPR-Cas-Based Genome Editing for Treating Human Diseases-Part A, Volume 208 represents CRISPR-Cas systems for genome editing.Currently, CRISPR-Cas systems are proven a key technology for targeted genome editing, which is acting as a simple, rapid, and cost-effective solution.
Item Description:2.3 Protein-based systems.
Physical Description:1 online resource (310 pages).
Bibliography:Includes bibliographical references and index.
ISBN:9780443315886
0443315884
9780443315893
0443315892